Sophiris Bio Inc. (NASDAQ: SPHS) ("Sophiris"), a biopharmaceutical company developing PRX302 (topsalysin) for the treatment of urological ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE